The clinical impact of genetic testing in comprehensive cardiomyopathies
P/LP genetic variants are associated with earlier disease onset; however, they do not appear to influence the severity of myocardial fibrosis or the recurrence of arrhythmias following catheter ablation. Genetic testing is recommended for younger patients presenting with cardiomyopathy, although further investigation is warranted to clarify its impact on therapeutic responses.
Authors
- Teruhiko Imamura (ORCID: https://orcid.org/0000-0002-7294-7637)
- Naoya Kataoka (ORCID: https://orcid.org/0000-0001-7097-2495)
- Koichiro Kinugawa (ORCID: https://orcid.org/0000-0003-0009-8477)
- Keisuke Uchida (ORCID: https://orcid.org/0009-0007-2949-9617)
Institutions
- Toyama College (JP)
- University of Toyama (JP)
Publication Details
- Journal
- Journal of Cardiology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.jjcc.2025.12.008
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00